Comparing Rezum and Urolift
This is a randomized controlled trial using a non-inferiority design with the subjects randomized 1:1 to either water vapour thermal treatment (REZUM) arm or prostatic urethral lift (UroLift) arm.
Prostate Cancer
DEVICE: Rezum|DEVICE: UroLift
Changes in International Prostate Symptom Score (IPSS) at 12 months after treatment, IPSS score ranging from 0-35 (the higher the worse), Baseline, 3 months, 6 months and 12 months after intervention
Hospital stays of procedure, Measure the hours of in-patient hospitalisation, From the time patient is hospitalised until the time he discharges|Number of days on Foley's catheter or self-catheterization after operation, 30 days after intervention|Complication rate, Assessed by Clavien-Dindo classification, 30 days after intervention|Post-op quality of life score (International Prostate QOL score), Change in quality of life assessed by change in International Prostate QOL score (Ranges from 0 to 6; 0 being the best while 6 being the worst), Baseline, 3 months, 6 months and 12 months after intervention|Post-op quality of life score (EQ5D-5L questionnaire), Change in quality of life assessed by Quality of life: EQ5D-5L questionnaire, Baseline, 3 months, 6 months and 12 months after intervention|Change in voiding function in uroflowmetry (Maximum flow rate), It is assessed by maximum flow rate (ml/s) in uroflowmetry, Baseline, 3 months, 6 months and 12 months after intervention|Change in voiding function in uroflowmetry (Post void volume), It is assessed by post void volume (ml) in uroflowmetry, Baseline, 3 months, 6 months and 12 months after intervention|Post-op erectile function (IIEF-EF), Assessed by Erectile function and Ejaculatory function using International Index of Erectile Function Questionnaire - Erectile function domain (IIEF-EF), Baseline, 3 months, 6 months and 12 months after intervention|Post-op erectile function (MSHQ-EjD-SF), Assessed by Erectile function and Ejaculatory function using Male Sexual Health Questionnaire - ejaculatory dysfunction (EjD) Short Form (MSHQ-EjD-SF), Baseline, 3 months, 6 months and 12 months after intervention|Unplanned readmission rate after operation in 30 days, Percentage of patients with unplanned readmission, 30 days after intervention|Cost of procedure and related hospitalization, At 12 months after treatment
This is a randomized controlled trial using a non-inferiority design with the subjects randomized 1:1 to either water vapour thermal treatment (REZUM) arm or prostatic urethral lift (UroLift) arm.